Global Ureteral Stents Market - 2022-2029

Global Ureteral Stents Market - 2022-2029

Market Overview

Ureteral Stents Market is expected to grow at a CAGR of 5.8% during the forecasting period (2022-2029).

Ureteral stents are thin, flexible tubes that restore urine flow through blocked ureters due to various disorders. Innovative interface platforms available in the market for stent case management and patient safety are useful for both patients and physicians. Epidemiological data revealed that the prevalence of kidney stone disease is increasing, which further increases the demand for ureteral stents.

Market Dynamics

The global ureteral stents market is driven by the rising incidence of urological diseases, the rising geriatric population with kidney disorders, and an increasing number of kidney transplants.

The rising number of kidney transplants and the growing geriatric population fuel the growth of the global market.

The increasing number of kidney transplants is expected to drive the market. For instance, according to the Global Observatory on Donation and Transplantation, in 2020, there were over 80,926 kidneys donated, and in 2021 around 98,349 kidneys were donated. The median wait time for an individual's first kidney transplant is around 3.6 years and varies depending on compatibility, health, and availability of organs. According to the report published by NHS Blood and Transplant, which works in collaboration with NHS England, the active waiting list as of 24 February 2022 has 4,658 patients waiting for a kidney, including 98 children. This number is expected to rise. Thus, the growing number of renal transplants and raising concerns related to urological dysfunction have surged the demand for ureteral stents for post-operative convenience.

Furthermore, the growing geriatric population is expected to drive the global ureteral stents market. For instance, as per World Health Organization, the number of people aged 65 is expected to rise from an estimated 1 billion in 2020 to 1.4 billion in 2030; the world's geriatric population will double (2.1 billion) by 2050 and between 2020 and 2050, the persons aged 80 years or older will reach to 426 million, with most of the increase in developing countries. This increase in geriatrics will be reflected by the rise in medical problems such as kidney stones. It requires coordinated care by multiple specialties, with geriatricians and nephrologists playing a vital role in treating these patients.

The high risk of complications post-stent removal will hamper the global market growth.

However, the high risk of complications after the removal of stents is likely to restrain the market. Some complications related to dislocation, blockage, and infection may arise because of the usage of a urinary stent. The patient may also feel an increased urgency or frequency of urination, kidney pain, and blood in the urine. These factors surge the medical research and development departments to develop a better alternative to ureteral stents and can affect the market growth in the forecast period.

Industry analysis

The global ureteral stents market report will provide an in-depth analysis of the market based on various industry factors such as porter`s five forces, innovations, new product launches, pricing, Etc.

Segment Analysis

The multiloop stents segment is predicted to dominate the global market during the forecast period (2022-2029).

The multiloop stents segment is expected to grow at the highest rate during the forecast period (2022-2029) because of the rise in the prevalence of urological disorders, the growing geriatric population, and technological advancements in the multiloop stents segment associated with reduced complications. Also, the high adoption of these stents and the adoption of various marketing strategies by critical vendors foster its growth. The Multiloop Ureteral Stent is intended to temporarily facilitate urine drainage from kidney to bladder by a trained physician. One of the market leaders on the multiloop ureteral stents front is MEDpro Medical, with their successful Double J Stent one-end multiple loops and Double J Stent, both end multiple loop products. Also, the Biliary double J stent, both end multiple loops of Surgimedik, is one of a kind.

Geographical Analysis

North America is estimated to command the global ureteral stents market.

North America dominated the global ureteral stents market in 2021 and is estimated to hold a significant market size over the forecast period (2022-2029) owing to the rising incidences of urological diseases like chronic kidney diseases, kidney stones, Etc., rising geriatric population base, increasing sedentary lifestyles, growing kidney transplantations. For instance, according to LifeSource statistics, as of July 20, 2022, over 89,898 United States citizens are waiting for a lifesaving kidney transplant. Furthermore, as per Kidney.org, more than half a million people yearly go to emergency rooms stones one problem. In addition, the US-based major players are adopting various strategies, including product launches, company expansion, mergers, and others, fueling the market's growth in North America. For instance, University Hospitals Cleveland Medical Center is developing the RELIEF™ Ureteral Stent in clinical trials to assess Retrograde Urinary Reflux and Distal Coil Bladder Position. It is a single-use, disposable ureteral stent device which provides the traditional function of allowing the passage of urine from the kidney to the bladder with new design enhancements, also with the benefits of minimizing urinary reflux and decreasing irritative bladder symptoms to improve patient care. According to the reports, the estimated study completion date is December 2022.

Competitive Landscape

The major players operating in the global ureteral stents market are Boston Scientific Corporation, B. Braun Holding GmbH & Co. KG, Cook Group Incorporated, Coloplast Ltd., C. R. Bard, Inc., Medline Industries, Inc., Allium Medical Solutions Ltd, Penn Medical A/S, Teleflex Incorporated, and Olympus Corporation. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the ureteral stents market globally. For instance, on 02 May 2022, Cook Medical’s Winston-Salem manufacturing facility secured ISO 14001 Certification. Also, on May 28, 2021, Olympus Corporation acquired Medi-Tate, an Israeli Medical Device Company.

Boston Scientific Corporation

Overview:

Boston Scientific Corporation is a leading biomedical/biotechnology engineering Company involved in the global production of medical devices that are used in interventional medical specialties, such as interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific was founded in 1979 and is headquartered in Marlborough, Massachusetts, U.S.

Product Portfolio:

Boston Scientific Corporation’s product portfolio for ureteral stents has

Contour Ureteral Stents, Contour Injection Ureteral Stent Set, Percuflex Urinary Diversion Stent Set, Percuflex Ureteral Stent, Polaris Loop Ureteral Stent,

Polaris Ultra Ureteral Stent, Retromax Plus Endopyelotomy Stent, Stretch VL Flexima Ureteral Stent Set, Tria Ureteral Stents, Etc.

The global ureteral stents market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.